Immunotherapy drug effective for metastatic triple negative breast cancer
Sunday, June 4, 2017 - 13:22
in Health & Medicine
The immunotherapy drug, Pembrolizumab, is effective in shrinking tumors among metastatic triple negative breast cancer patients as found in a clinical trial.